QIAGEN (QGENF) - Star of Germany's Biotechs Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QIAGEN (QGENF) - Star of Germany's Biotechs

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Zeitgeist who wrote (17)	5/19/1997 10:39:00 PM
From: Jaipal Patheja	of 122

Zero Growth Company Stefan, You seem knowledgeable of the operations of this company. I can get little information in that regard. Accordingly, please feel free to refute/support my observations with information that I currently lack. This company boasted 100% growth in its last earnings report. Unfortunately, the financial statements revealed that QGENF's jump from $1 million to $2 million in income was derived entirely from collection of a RESEARCH GRANT and interest on the money collected from the IPO. In other words, there was no growth from operations! Furthermore, insiders have been filing Form 144's to sell this stock on a regular basis since late March 1997.( I don't know what the lockout period is, but the IPO happened to occur last June.) So why does the price keep going up? I would love to sell a lot (more) of this stock short. Is there any reason not to?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next